The goal of this clinical trial is to evaluate a new way of helping adolescents with type 1 diabetes consistently use continuous glucose monitoring systems (CGM).

Families who participate will be assigned by chance to one of two groups. One group will continue to see their Endocrinology provider who can give recommendations on ways to use CGM.

The other group will be in our Type 1 Together program for 6 months. This will include:

1. Monthly meetings with a community health worker with expertise in type 1 diabetes self-management,
2. Access to CGM-specific educational resources hosted on a mobile app, and
3. Meeting at least monthly with a mentor family who will provide mentorship on using CGM consistently.

The main questions the study aims to answer are:

1. Do families like the Type 1 Together program?
2. Do more families in the Type 1 Together program have better attitudes towards CGM, use CGM more consistently, and have lower HbA1c?
3. Does the Type 1 Together program reduce racial and ethnic differences in attitudes towards CGM, consistent use of CGM, and HbA1c?

Inclusion Criteria:

• 12 to 17 years old
• Diagnosed with type 1 diabetes for at least 6 months
• Does not use CGM OR uses CGM < 24 out of the past 30 days
• Use CGM 24 to 30 of the past 30 days but most recent HbA1c was 9% or more
• Able to read and write in English

Exclusion Criteria:

• Type 1 diabetes due to other medical condition (e.g., cystic fibrosis)
• Intellectual disability
• Severe psychiatric comorbidities